FDA Inspection
Andrew C Sedillo, MDAndrew C Sedillo, MD – FDA Inspection, Sep 3, 2026
Record Details
This FDA Inspection record concerns Andrew C Sedillo, MD, with an inspection on September 3, 2026, issued by the Denver District Office, covering human drugs.
View Company Profile
ID · 55683424-1fab-433c-bffe-18964e40e053
Inspection Facts
- Inspection number
- 1334832
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Andrew C Sedillo, MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2025 | VAI | Denver District Office | Bioresearch Monitoring: Human Drugs |
| October 11, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 16, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 2, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Andrew C Sedillo, MD
- FDA Inspection 1269750 - 2025-05-07
- FDA Inspection 1108035 - 2019-10-11
- FDA Inspection 1044979 - 2018-02-16
- FDA Inspection 982272 - 2016-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.